Understanding how bacteria adapt to survive antibiotic treatment

Rapid Stress Response in Bacterial Pathogens: the Role of Extant Porins in Antibiotic Tolerance

NIH-funded research Texas Engineering Experiment Station · NIH-11168200

This study looks at how certain harmful bacteria can become resistant to antibiotics by changing their outer layer, focusing on special proteins that help antibiotics get inside the bacteria, with the goal of finding new ways to fight infections that don't respond to treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station NIH-funded
Lab location1 site (College Station, United States)
Project IDNIH-11168200 on NIH RePORTER

What this research studies

This research investigates how Gram-negative bacterial pathogens develop tolerance to antibiotics through rapid changes in their outer membrane. It focuses on the role of porins, which are proteins that control the entry of antibiotics into bacterial cells. By studying how these bacteria can quickly inhibit the function of existing porins when exposed to antibiotics, the research aims to uncover new mechanisms of antibiotic resistance. This could lead to better strategies for combating antibiotic-resistant infections.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant Gram-negative bacteria.

Not a fit: Patients with infections caused by non-Gram-negative bacteria or those not affected by antibiotic resistance may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively overcome antibiotic resistance in bacterial infections.

How similar studies have performed: Other research has shown promising results in understanding bacterial resistance mechanisms, but this specific approach focusing on extant porins is relatively novel.

Where this research is happening

College Station, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.